W. Keith Hoots, M.D. joins NHLBI as Director, Division of Blood Diseases and Resources

Dr. Nabel - January 5, 2009

Dear Colleagues:

I am very pleased to announce that Dr. W. Keith Hoots, M.D. has joined us effective January 5th, 2009 as Director of our Division of Blood Diseases and Resources. Dr. Hoots comes to us from the University of Texas (UT) Medical School at Houston where he was Professor of Pediatrics and Division Head of Pediatric Hematology; Section Head of Pediatric Hematology, UT M.D. Anderson Cancer Center; and Medical Director, Gulf States Hemophilia and Thrombophilia Treatment Center. Dr. Hoots also directed the Fellowship Program at M.D. Anderson.

Dr. Hoots received his A.B. in English and Chemistry and his M.D. from the University of North Carolina (UNC) in Chapel Hill, North Carolina. While a senior at UNC, he worked in the hemostasis laboratory of Dr. Kenneth Brinkhous. He then completed his Pediatric Internship and Residency at Children's Medical Center, Parkland Memorial Hospital in Dallas, Texas. He returned to UNC for his Fellowship in Pediatric Hematology Oncology and worked in the laboratory of Dr. Harold Roberts. Dr. Hoots then joined the faculty at M.D. Anderson. Keith's major interests involve the management and diagnosis of congenital and acquired bleeding disorders and clotting disorders. His work includes the creation of longitudinal follow-up of hemophilia cohorts with HIV and hepatitis, gene therapy trials for Hemophilia A and B, clinical trials of new clotting concentrates for Hemophilia A and B, and the impact of care and clotting factor product on Hemophilia patient outcome. He also has a 20 year interest in the diagnosis and treatment of diffuse intravascular coagulation (DIC), in particular DIC in head trauma. He has been intimately involved in the development of safe coagulation factor products, having completed his training as the HIV epidemic was evolving in hemophilia patients. By the late 1980’s, he was able to return to the hemostasis focus which initially attracted him to the field, and he has continued to be a productive investigator and collaborator. He has a strong interest in global collaborations and in developing public-private partnerships and recently completed his sabbatical in Belgium.

Keith is a past member of the U.S. Department of Health and Human Services Blood Safety and Availability Advisory Committee to the Secretary of Health, past chair of the Medical and Scientific Advisory Committee for the National Hemophilia Foundation and subcommittee co-chair of the DIC Subcommittee of International Society of Thrombosis and Hemostasis. He has also been an associate editor for Seminars in Thrombosis and Hemostasis and served on the editorial boards of Haemophilia, Haemophilia Forum and the International Monitor on Hemophilia. He is a past president of the Hemophilia Research Society of North America.

Dr. Hoots is looking forward to meeting our talented staff and exploring exciting new directions for the Institute.

Twitter

Facebook

YouTube